display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
metastatic/advanced - colorectal cancer (mCRC)
endometrial cancer
poly ADP-ribose polymerase (PARP) inhibitor
niraparib RUBY ...

Study type: